XML 59 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Class a Common Stock Subject to Possible Redemption (Tables)
5 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2021
Dec. 31, 2020
Class a Common Stock Subject to Possible Redemption (Tables) [Line Items]      
Schedule of Amounts Recognized in Balance Sheet [Table Text Block]

Gross proceeds from issuance of potentially redeemable Class A common stock

 

$

115,000,000

 

Less:

 

 

 

 

Proceeds allocated to Public Warrants

 

 

(3,105,000

)

Class A common stock issuance costs

 

 

(6,793,491

)

Plus:

 

 

 

 

Accretion of carrying value to redemption value

 

 

9,898,491

 

Class A common stock subject to possible redemption

 

$

115,000,000

 

Gross proceeds from issuance of potentially redeemable Class A common stock

 

$

115,000,000

 

Less:

 

 

 

 

Proceeds allocated to Public Warrants

 

 

(3,105,000

)

Class A common stock issuance costs

 

 

(6,793,491

)

Plus:

 

 

 

 

Accretion of carrying value to redemption value

 

 

9,898,491

 

Class A common stock subject to possible redemption

 

$

115,000,000

 

 
Ambulnz, Inc. [Member]      
Class a Common Stock Subject to Possible Redemption (Tables) [Line Items]      
Schedule of fair value of the sole stock option grant  
 

Quarter Ended September 30,

   

2021

 

2020

Volatility

 

65%

 

44.48%

Expected term (in years)

 

.5 – 2

 

2%

Risk-free interest rate

 

.15% – .62%

 

.14% – 1.58%

Dividend yield

 

0

 

0

 

For the Years Ended
December 31,

2020

 

2019

Risk-free interest rate

 

0.14% – 1.58%

 

1.58% – 1.66%

Expected term (in years)

 

2.0   

 

3.0   

Expected volatility

 

44.48%

 

39.28%

Dividend yield

 

%

 

%

Schedule of stock option activity under the Plan  
 

Number
of Shares
Outstanding

 

Weighted
Average
Exercise Price

 

Weighted
Average
Remaining
Contractual
Life in Years

 

Aggregate
Intrinssic Value

Balance at December 31, 2020

 

7,186

 

 

$

1,190

 

7

 

 

8,129,671

Stock Options grants

 

1,394

 

 

 

5,043

 

10

 

 

 

Stock options exercised

 

 

 

$

 

 

 

 

Stock option forfeited

 

(793

)

 

 

1,704

 

 

 

 

 

Balance at September 30, 2021

 

7,787

 

 

$

1,496

 

7

 

$

38,121,110

Vested or expected to vest at September 30, 2021

 

5,165

 

 

$

1,276

 

4

 

$

26,626,986

 

Options Shares

 

Weighted
Average
Exercise Price

 

Weighted
Average
Remaining
Contractual
Life in Years

 

Aggregate
Intrinsic
Value

Outstanding at January 1, 2019

 

4,250

 

 

$

1,415

 

 

7.81

 

$

1,344,800

Granted/Vested during the year

 

2,050

 

 

 

1,023

 

 

10.01

 

 

 

Exercised during the year

 

 

 

 

 

 

 

 

 

Cancelled during the year

 

(700

)

 

 

4,104

 

 

 

 

 

Balance, December 31, 2019

 

5,600

 

 

$

1,236

 

 

7.74

 

$

1,344,800

Granted/Vested during the year

 

1,605

 

 

 

1,073

 

 

9.11

 

 

 

Exercised during the year

 

 

 

 

 

 

 

 

 

Cancelled during the year

 

(19

)

 

 

(1,023

)

 

 

 

 

Balance, December 31, 2020

 

7,186

 

 

$

1,190

 

 

7.28

 

$

8,129,671

Options vested and exercisable at December 31, 2020

 

3,855

 

 

$

837.11

 

 

6.14

 

$

3,967,775